High incidence and low attendance OAB seriously affects quality of life, and some elderly patients use adult diapers and pads throughout the day. Most patients choose to limit water consumption, wear dark or loose fat clothing and go out less. When they go out, they think about finding the toilet first, draw a map of toilet distribution, and choose a location near the restroom or exit when taking public transportation such as airplanes and trains. In addition to psychological stress and mental tension, more serious is that OAB can also cause such as urinary tract infections, skin infections, sexual dysfunction, depression and many other related diseases, and even increase the risk of falls and fractures.
“Many misconceptions have led many OAB patients to neglect the disease, making the consultation and treatment situation not ideal.307 Hospital opened the OAB management clinic is to allow more OAB patients to understand the disease, facilitate access to medical care and relieve OAB distress.” Chen Lijun, director of the Department of Urology at 307 Hospital of the Chinese People’s Liberation Army, said with emotion. The prevalence of OAB in China is about 15.1%, and the number of OAB patients ranks among the top 10 of all chronic diseases, more common than diabetes and peptic ulcers. 2010 census results show that the accelerated development of China’s aging society will lead to a significant increase in the prevalence of OAB. OAB management clinics will make it easier and faster for these patients to receive professional medical care.
At present, the main treatments for OAB include lifestyle modification, behavior training, medication and surgery, etc. Among them, medication is the most widely used treatment internationally, and the mainstream drugs are anticholinergic drugs, i.e. M receptor antagonists. pointed out that medication can effectively relieve patients from urinary urgency, frequency and urge incontinence. It is reported that the OAB treatment guidelines of several countries include M-receptor antagonists such as tolterodine as the first-line medication choice for OAB treatment. Studies have shown that tolterodine is effective after one week of administration and usually treats for three months, but individual patients with severe disease may require long-term medication. Tolterodine is the number one selling OAB treatment drug worldwide. China has included the original tolterodine extended-release capsules in its medical insurance reimbursement, reducing patients’ concerns about cost.
OAB in men is often masked by prostate disease In clinical practice, OAB is often associated with or secondary to other lower urinary tract diseases, such as urinary tract infections, prostatitis or prostate enlargement, so it can easily be overlooked or misdiagnosed.